Ozempic-style drugs treat type 1 diabetes, not only type 2, study finds. Jennifer Zieba. Wed, July 2, 2025 at 9:00 PM UTC. When you buy through links on our articles, Future and its syndication ...

Ozempic and Mounjaro are both very popular for weight loss at the minute, but there's one big difference between the two ...

New research shows that most people regain weight after stopping Ozempic and similar weight-loss drugs around the eight-week ...

When you hear the name Ozempic, you likely think of diabetes treatment. That makes sense, as semaglutide was first approved in 2017 to help people with type 2 diabetes regulate […] ...

Many people stop taking GLP-1 drugs like Ozempic within a year, but doing so often leads to weight regain. Here's what to ...

The diabetes drugs Ozempic and Wegovy have been linked to an increased risk of sudden vision loss and blindness due to a rare ...

GLP-1 drugs like Ozempic have already become a game-changer for obesity and diabetes. But new research shows they may also ...

Mini meals with bite size portions are meant to appeal to people taking GLP-1 weight-loss drugs that reduce appetite.

In a study on people with obesity and asthma, researchers saw “significant” improvements in the asthma scores of people who had been on GLP-1 medications for a year.

Several anti-obesity drugs, including Ozempic, Wegovy and Mounjaro, have created buzz in the Indian markets. But are they really approved for use in India? What are their side-effects? And how much do ...

GLP-1 agonists, including liraglutide, are typically used to control blood sugar levels in type 2 diabetes and to promote weight loss. These drugs mimic a hormone released after eating, helping to ...

Ozempic-style drugs treat type 1 diabetes, not only type 2, study finds. News. By Jennifer Zieba published 2 July 2025 A clinical trial for semaglutide, the active ingredient in Ozempic, found ...